Cytokinetics CYTK Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$206.03M-12.6% | -$183.03M+40.2% | -$306.18M-128% | -$134.37M+16.7% | -$161.38M-7.6% | ||
| $3.38M+18.1% | $2.86M+6.8% | $2.68M+17.2% | $2.29M-0.7% | $2.3M-3.5% | ||
| $30.39M-0.4% | $30.51M-0.6% | $30.7M+11.5% | $27.54M+16.9% | $23.55M-10.3% | ||
| -$145.46M-2.0% | -$142.65M-32.7% | -$107.51M+16.2% | -$128.24M+2.6% | -$131.62M-101% | ||
| $5.93M+5.1% | $5.64M-39.7% | $9.35M+126% | $4.15M-26.8% | $5.66M+339% | ||
| $145.49M— | —— | —— | $52.88M-50.1% | $105.96M— | ||
| —— | $182.37M0.0% | $182.37M0.0% | $182.37M0.0% | $182.37M— | ||
| $2.74M+0.5% | $2.72M+0.5% | $2.71M+0.5% | $2.7M+0.5% | $2.68M+0.4% | ||
| $7.77M-93.0% | $110.71M-66.5% | $330.47M+321% | $78.53M+1,552% | $4.75M+99.4% | ||
| $7.32M— | —— | $152.03M— | —— | -$21.18M— | ||
| -$151.39M-2.1% | -$148.3M-26.9% | -$116.86M+11.7% | -$132.38M+3.6% | -$137.28M-105% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Cytokinetics generate?
- Cytokinetics (CYTK) generated -$523.8M in operating cash flow over the trailing twelve months.
- What is Cytokinetics's free cash flow?
- After $25.1M of capital expenditures, Cytokinetics's free cash flow was -$548.9M over the trailing twelve months, down 34.7% year over year.
- Where does Cytokinetics's cash flow data come from?
- Every line is extracted from Cytokinetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
